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Helicobacter pylori requires flagellar motility and orientation to persist actively in its habitat. A particular
feature of flagella in most Helicobacter species including H. pylori is a membraneous flagellar sheath. The
anti-sigma factor FlgM of H. pylori is unusual, since it lacks an N-terminal domain present in other FlgM
homologs, e.g., FlgM of Salmonella spp., whose regulatory function is intimately coupled to its secretion through
the flagellar type III secretion system. The aim of the present study was to characterize the localization and
secretion of the short H. pylori FlgM in the presence of a flagellar sheath and to elucidate its interaction with
other flagellar proteins, such as the basal body protein FlhA, which was previously shown to cooperate with
FlgM for regulation. H. pylori FlgM was only released into the medium in minor amounts in wild-type bacteria,
where the bulk amount of the protein was retained in the cytoplasm. Some FlgM was detected in the flagellar
fraction. FlgM was expressed in flhA mutants and was less soluble and differentially localized in bacterial
fractions of the flhA mutant in comparison to wild-type bacteria. FlgM-green fluorescent protein and FlgM-V5
translational fusions were generated and expressed in H. pylori. FlgM displayed a predominantly polar
distribution and interacted with the C-terminal domain of FlhA (FlhAC). We suggest that, in H. pylori, FlgM
secretion may not be paramount for its regulatory function and that protein interactions at the flagellar basal
body may determine the turnover and localization of functional FlgM.
ticular of the major filament protein FlaA (6, 24). Interestingly,
H. pylori FlgM is truncated at its extreme N terminus in comparison to its counterpart in Salmonella. Still, H. pylori FlgM is
functional as an anti-sigma factor in Salmonella (24). FlgM in
H. pylori is a central component in the regulation of flagellar
genes. It is important at all regulatory levels and not only for
the regulation of late flagellar genes (33). In H. pylori and
numerous other Helicobacter spp., the presence of a flagellar
sheath is a common and conspicuous trait and raises the question of whether FlgM secretion through the flagellar central
channel into the environment is possible or whether it might be
hampered under these circumstances. In Salmonella, FlgM secretion is crucial for its function as an anti-sigma factor, as
FlgM secretion from the bacterial cytoplasm through the
flagellar type III secretion system itself is intimately coupled to
its regulatory function (15, 20). An unusually short FlgM is
found not only in H. pylori but also in other Campylobacterales
species whose whole genome sequences have been decoded
(e.g., Helicobacter mustelae, Helicobacter hepaticus, Campylobacter coli, Campylobacter jejuni, Wolinella succinogenes [12,
35, 44; P. W. O’Toole et al., Sanger Center, unpublished
data]). It is assumed that the type III secretion signal of FlgM
is encoded in its N-terminal amino acid sequence as in other
type III secreted substrate proteins (43). Proposed evolutionary degeneration at the N terminus of FlgM in all of the
Epsilonproteobacteria may therefore suggest that the type III
secretion signal responsible for secretion of FlgM is not
present in those bacterial species. This raises the question of

Helicobacter pylori causes chronic infection of the human
stomach mucosa in about 50% of the world population. H.
pylori requires flagellar motility and taxis for persistent survival
in the gastric mucus of humans (11, 23, 27, 40). The flagellar
apparatus of H. pylori shows some specific properties. The
bacterium may have acquired those properties as an adaptation to an inhospitable environment of low pH and high proteolytic activity (e.g., pepsin), which may be damaging to flagellar components and function. In particular, a flagellar sheath
covers each flagellum and is continuous with the bacterial
outer membrane and of similar lipid composition (14).
Many H. pylori flagellar components are similar to the wellcharacterized flagellar apparatus of Salmonella spp. (3, 30).
The complex hierarchical regulation of flagellar genes in H.
pylori (24, 33, 51) suggests that flagellar components in this
species are also assembled in a highly ordered fashion. The
anti-sigma factor FlgM and the sigma factor FliA jointly control the expression of late flagellar genes in H. pylori, in par-
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TABLE 1. Strains used in this study
Genotypea

Strain

E. coli strains
DH5␣
ER2566
MC1061
TG1
BTH101
a

Wild-type strain
Motile variant of 26695
Wild-type stain
N6 flhA::aphA3⬘-III
N6 flgM::aphA3⬘-III
N6 fliA::aphA3⬘-III
N6 fliI::aphA3⬘-III
N6 rpoN::aphA3⬘-III
88-3887 flgM::aphA3⬘-III
88-3887 flhA::aphA3⬘-III
88-3887 fliP::aphA3⬘-III
88-3887 fliI::aphA3⬘-III
88-3887 fliF::aphA3⬘-III
N6 flhF::aphA3⬘-III
N6 ⫹ plasmid pCJ604
N6 flgM::aphA3⬘-III ⫹ plasmid pCJ604 (FlgM-GFP)
N6 fliA::aphA3⬘-III ⫹ plasmid pCJ604 (FlgM-GFP)
N6 flhA::aphA3⬘-III ⫹ plasmid pCJ604 (FlgM-GFP)
N6 fliI::aphA3⬘-III ⫹ plasmid pCJ604 (FlgM-GFP)
N6 flgM::aphA3⬘-III ⫹ plasmid pCJ607 (FlgM-V5)

45
21
13
39
24
24
This
33
24
33
21
This
This
33
This
This
This
This
This
This

F⫺ endA1 recA1 hsdR17 ⌬(lacZYA-argF)U169 thi1 supE44 gyrA96 relA1
F⫺ ⫺ fhuA2[Ilon], ompT lacZ::T7 gene I gal sulA11⌬(mcrC-mrr)11::IS10 R
(mcr-73::miniTn10)2 R(zgb-210)::Tn10)1 (Tets) endA1 [dcm]
F⫺ araD139 ⌬(ara-leu)7696 galE15 galK16 ⌬(lac)X74 rpsL (Strr) hsdR2 (rK⫹ mK⫹)
mcrA mcrB1
Expression of FlhAC
Cya-BACTH expression strain; F⫺ cya-99 araD139 galE15 galK16 rpsL1 (Strr)
hsdR2 mcrA1 mcrB1

17
New England
Biolabs
5

study

study
study
study
study
study
study
study
study

38
25

Kmr (aphA3⬘-III), kanamycin resistance cassette (28).

whether FlgM cannot be secreted in those bacteria. Under
those circumstances, secretion may not be essential for FlgM
function.
Our previous data on flagellar transcriptional regulation in
H. pylori flhA flgM double knockout mutants (33) indicated
that inactivation of flgM resulted in a partial suppressor mutation over a previous inactivation of flhA. It is of interest that
the transcriptional regulatory phenotype of wild-type bacteria
was reconstituted in the double mutants. Despite the regulatory suppressor phenotype, the morphological flagellar phenotype was not reconstituted back to wild type (33). This was
probably due to the total lack of FlhA protein in those mutants. Thus, the hypothesis was generated that FlhA and FlgM
cooperate closely or may physically interact in order to coordinate flagellar gene regulation.
The goal of this study was therefore to establish whether
FlgM is secreted from the H. pylori cell and to determine FlgM
expression and localization in wild-type H. pylori and flagellar
mutants with defined defects in flagellar regulation and flagellar secretion. We also hypothesized that protein-protein interactions at the flagellar basal body, in particular with FlhA, may
be required for the function and localization of H. pylori FlgM.
In this study we found that FlgM is only secreted in small
quantities from H. pylori wild-type cells. Furthermore, FlhA
had an influence on the localization of FlgM, and interaction
between FlgM and the C-terminal domain of FlhA (FlhAC)
was demonstrated by several methodologies.

MATERIALS AND METHODS
Bacterial strains and culture conditions. H. pylori strains N6 (13) and 88-3887
(motile variant of the fully sequenced strain 26695 [21]) were used. The bacterial
strains and H. pylori mutants used are listed in Table 1. Bacteria were routinely
cultured on blood agar plates (Oxoid blood agar base and 5% horse blood) or in
brain heart infusion broth supplemented with 2.5% yeast extract and 10% horse
serum and the following antibiotics: vancomycin (10 mg/liter), polymyxin B
(2,500 U/liter), trimethoprim (5 mg/liter), and amphotericin B (4 mg/liter). The
selective antibiotics included ampicillin (300 mg/liter), kanamycin (20 mg/liter),
and chloramphenicol (10 mg/liter) and were added to the media as required.
Escherichia coli strains used for cloning were DH5␣ and MC1061 (38), and for
overexpression of proteins, the strains ER2566 (New England Biolabs Inc.) and
TG1 (38) were employed.
Techniques of molecular cloning and protein analysis. DNA purification,
DNA manipulation, and cloning procedures were performed according to standard protocols (38). PCRs were run in Perkin-Elmer or Biometra thermocyclers
using Amersham Taq polymerase. The Expand High-Fidelity kit (Roche) was
used for longer fragments (⬎2 kb) or if high amplification accuracy for protein
expression was required. Plasmids are listed in Table 2. Protein analysis was
performed using denaturing sodium dodecyl sulfate (SDS)-polyacrylamide gels
containing between 11% and 16% acrylamide, depending on the molecular mass
of the proteins to be detected (29), and applying Western immunoblot detection
according to the methods described by Towbin (46). Antibodies for immunolabeling were used as indicated in the results or in the figure legends. Protein
concentrations were determined using the bichinchoninic acid assay. H. pylori
was transformed with plasmids by natural transformation or electroporation. H.
pylori crude flagellar preparations and bacterial lysates were obtained as previously described (23, 41).
Crude fractionation of bacteria. Bacteria, grown either on plates or in liquid
culture to defined optical densities, were fractionated into supernatant, insoluble
(membrane-enriched), and soluble (cytoplasmic) fractions. Also, the surface
appendages containing flagella and other surface-associated material were iso-
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H. pylori strains
26695
88-3887
N6
N6flhA
N6flgM
N6fliA
N6fliI
N6rpoN
88-3887flgM
88-3887flhA
88-3887fliP
88-3887fliI
88-3887fliF
N6flhF
N6(pCJ604)
N6flgM(pCJ604)
N6fliA(pCJ604)
N6flhA(pCJ604)
N6fliI(pCJ604)
N6flgM(pCJ607)

Reference
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TABLE 2. Plasmids constructed or used in this study

Plasmid

pCJ105

pUT18C-ZIP
pKT25-ZIP
pCJ309
pSUS225

Reference or
source

pHel2
pUC18
pHel2

Cmr RepEc RepHp; multicopy shuttle vector for E. coli and H. pylori
Apr RepEc, high-copy-number cloning vector
RepEc RepHp flgM-FLAG tag fusion; flgM from H. pylori 26695

pEF6-V5
pUC18
pHel2
pHel2
pBR322
pSUS2/pUC18
pUC18
pUC18
pKNT25 (BACTH)
pUT18 (BACTH)
pUT18 (BACTH)
pKNT25 (BACTH)
pUT18C (BACTH)
pKT25 (BACTH)
pTWIN1 (NEB)
pQE30 (Qiagen)

RepEc RepHp Ampr Blastr; source of V5 sequence
Apr Kmr RepEc fliI::aphA3⬘-III; fliI from H. pylori 88-3887
RepEc RepHp Cmr flgM-gfpmut2 fusion; flgM from H. pylori 88-3887
RepEc RepHp Cmr flgM-V5 tag fusion; flgM from H. pylori 88-3887
Apr Kmr RepEc; source of Kmr cassette (aphA3⬘-III)
fliF-aphA3⬘-III
flhB2-aphA3⬘-III
flhB1-aphA3⬘-III
RepEc Kmr flhAC-t25 gene fusion flhAC from strain N6
RepEc Apr flgM-t18 gene fusion flgM from strain 26695
RepEc Apr
RepEc Kmr
RepEc Apr, leucin zipper gene
RepEc Kmr, leucin zipper gene
RepEc Apr, H. pylori FlgM expression plasmid
RepEc Apr, H. pylori His6-FlhAC expression plasmid

18
48
C. Josenhans,
unpublished
41
This study
This study
This study
28
This study
This study
This study
This study
This study
25
25
25
25
This study
39

a
Apr, ampicillin resistance; Kmr, kanamycin resistance; Cmr, chloramphenicol resistance (50); Blastr, blasticidin resistance; RepEc and RepHp, replication origin for
E. coli and H. pylori, respectively.

lated as previously described (21). Briefly, liquid culture bacteria were harvested
by centrifugation (4,500 ⫻ g for 20 min at 4°C). The cell culture supernatant was
removed and further purified according to a method originally developed for
Salmonella by Hughes and Karlinsey (26). The supernatant was first sterile
filtered through a 0.22-m-pore-size MillexR-GV polyvinylidene difluoride
membrane. The cell-free supernatant was then filtered through a Protran nitrocellulose immobilization membrane (Schleicher & Schuell, Germany), which
binds proteins present in the cell-free suspension. The membrane was then
bathed in 20 to 25 l of SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
sample buffer to elute the concentrated proteins from the membrane, which were
loaded onto SDS-PAGE gels. For isolation of flagellar fractions, the bacterial
pellets were resuspended in 0.9% NaCl and subjected to mild shearing forces by
repeated (30 times) pushing of the suspension through 26-gauge syringe needles
to shear off appendages from the bacterial surface. Intact bacterial cells and the
sheared-off material were then separated by differential centrifugation steps (first
at 9,000 ⫻ g for 30 min followed by 40,000 ⫻ g for 1 h in a Beckman Optima100
ultracentrifuge). The quality of the surface preparations was confirmed by electron microscopy and by Western immunoblotting using flagellin-specific antisera.
These controls confirmed that the protocol successfully isolated surface-associated material. The separation of bacteria into insoluble (mainly membraneassociated) and soluble (predominantly cytoplasmic) fractions followed after the
separation from the sheared-off material. The intact bacterial cells were resuspended again in 0.9% NaCl and lysed by sonication (Branson sonifier). After
centrifugation (two times at 9,000 ⫻ g for 30 min at 4°C), the pellet was resuspended in 0.9% NaCl and contained the crude membrane fraction, whereas the
supernatant represented the soluble fraction. The quality of the fractionation
procedure to isolate insoluble and soluble fractions was tested by electron microscopy and by Western blot analysis for membrane proteins (using antiHPFlhA antiserum).
RNA preparation and RT-PCR. RNA was prepared from H. pylori bacteria
harvested from liquid cultures in different growth phases using the Qiagen
RNeasy kit with slight modifications as described elsewhere (24). Semiquantitative reverse transcription-PCRs (RT-PCRs) were performed on 2 g of DNase
I-treated RNA samples. Reverse transcription was performed using a random
hexamer primer mix and SuperScript III reverse transcriptase (Invitrogen) at
42°C for 2 h. The cDNA was adjusted to 50 l with double-distilled H2O.
One-microliter aliquots of cDNA sample were amplified in different PCRs (including negative controls) with primers specific for the corresponding genes. H.
pylori 16S rRNA-specific primers were used in each experiment to verify that
comparable amounts of cDNA were used.
Construction of H. pylori flagellar mutants. Plasmid constructs for three additional flagellar mutants (fliI, gene for flagellar ATPase [32, 36]; fliF, flagellar
MS ring protein gene [30]; and flhB1 and flhB2, genes for flagellar basal body

proteins cooperating with FlhA [30]) were generated in E. coli. In brief, PCRamplified fragments of the genes were cloned into pUC18 or pILL570. Antibiotic
resistance cassettes were inserted into the 3⬘ parts of the genes either by inverse
PCR amplification of the plasmids or using natural restriction sites. Insertion of
the cassettes was in the same orientation with respect to the target gene, in order
to avoid polar effects. Resulting suicide plasmids (Table 2) were then introduced
into H. pylori strains N6 and the motile isogenic clone 88-3887 of 26695 (21) by
natural transformation as described previously (16). Transformants or allelic
exchange mutants were selected on kanamycin- or chloramphenicol-containing
plates. The genotypes of the mutants were verified by PCR using different
combinations of oligonucleotide primers. All mutant clones were verified by
PCR to carry the genomic disruptions as a result of a double-crossover and not
a single-crossover event. Details of the mutant constructions and oligonucleotide
primers are provided in the supplemental material. In addition, we used H. pylori
mutants in flhA (39), fliP (21), flgM and fliA (24), and rpoN and flhF (33) that had
been previously generated and characterized.
Construction of FlgM-GFP and FlgM-V5 transcriptional fusion plasmids for
complementation in H. pylori in trans and for localization studies. (i) FlgM-GFP.
For the expression of a FlgM-green fluorescent protein (GFP) fusion in H. pylori,
a plasmid was constructed starting with pCJ105 (FlgM-FLAG [C. Josenhans,
unpublished data]), which contains the H. pylori flgM gene followed by a FLAG
tag sequence. This tag was removed via inverse amplification (primers HPFlgM_GFP_1
and HPFlgM_GFP_2; both BglII sites). Using oligonucleotides GFP-FlgM_1
and GFP-FlgM_2 (BglII sites) the gene encoding a red-shifted and enhanced
GFP variant, GFPmut2 (7), was amplified. Both amplification products were cut
and ligated to yield plasmid pCJ604 (FlgM-GFP), from which a FlgM protein
with a C-terminally fused GFP protein could be expressed in H. pylori. The
shuttle plasmid pCJ604 was transformed into H. pylori N6 wild type and also for
comparison into N6flgM, N6flhA, N6fliI, and N6fliA mutant strains by natural
transformation (50), yielding chloramphenicol-resistant colonies. The rationale
for using a fliI mutant was that it is expected to be impaired for separation of
FlgM from its chaperone FliA (36). The transformants were characterized by
PCR, RT-PCR, Western blot analysis, transmission electron microscopy, and
immune fluorescence.
(ii) FlgM-V5. The flgM gene, including its own untranslated 5⬘ region containing putative promoter sequences, was also C-terminally fused to a V5 tag sequence (GKPIPNPLLGLDST) with a 7-amino-acid linker (GGSSAAG [4]) and
cloned into the E. coli/H. pylori shuttle plasmid pHel2 (18). Initially, the vector
pEF6-V5 (Invitrogen) was amplified by inverse PCR using primers (OLpEF6_R
and OLV5_F) and including the sequence encoding the 7-amino-acid linker
(GGSSAAG) fused to the 5⬘ end of the encoded V5 tag (from plasmid pCJ521
[41]). The PCR product was digested with BglII and ligated with the BamHIdigested PCR product of the flgM gene (pCJ606). The flgM gene had been
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pCJ521
pCJ601
pCJ604
pCJ607
pILL600
pSUS1608
pSUS1614
pSUS1620
pCJ1001
pCJ1004

Descriptiona

Vector
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nal anti-V5 antibody (dilution of 1:500; Invitrogen) and goat anti-mouse-Alexa488 (1:5,000; Invitrogen) as a secondary antibody. Labeling with anti-V5
monoclonal antibody, in contrast to anti-GFP polyclonal serum, did not detectably stain all bacteria for FlgM-V5, and this was reproduced several times. We
assume that this is due to the single epitope being recognized by the antibody,
which may be masked in some states of FlgM, e.g., when it is in a stable complex
with FliA.
Protein coprecipitations. Coprecipitations (pull-down assays) were performed
either with highly purified H. pylori FlgM or His6-FlhAC proteins or with bacterial lysates which were sonicated in modified radioimmunoprecipitation assay
(RIPA) buffer (1% Nonidet P-40, 100 mM NaCl, 25 mM Tris-HCl, pH 7.5, 10%
glycerol, 20 mM imidazole, 0.1% Tween 20) and cleared by centrifugation to
contain only soluble proteins. In the case of purified recombinant proteins (see
above), His6-FlhAC (5 g) and FlgM (2 g) were mixed and modified RIPA
buffer was added to a total volume of 500 l. The samples were sonicated for 2
min at 4°C and incubated with the buffer for 1 h at 4°C with rotation. They were
further incubated for 2 h at 4°C with 25 l of TALON metal affinity resin
(Clontech), which had been prewashed three times with ice-cold PBS. The
samples were centrifuged at 1,006 ⫻ g for 1 min at 4°C, and the TALON resin
pellets were washed three times with modified RIPA buffer (without Nonidet
P-40) and two times with ice-cold PBS. The proteins were eluted from the
TALON beads by incubating at 100°C for 10 min in 30 l of 2⫻ SDS-PAGE
sample buffer. Alternatively, for pull-down from bacterial lysates, the amount of
FlhAC or FlgM-V5 in the respective lysates was determined in Western blot
assay and compared to purified proteins loaded in adjacent lanes. Equivalent
amounts of cleared lysates, containing approximately 5 g of His6-FlhAC and 2
g of FlgM, were then used for the experiments. Purified FlgM (2 g) was mixed
with cleared lysate of E. coli expressing recombinant H. pylori His6-FlhAC. In this
case, control experiments using the same amount of His6-FlhAc-expressing lysate
only were always performed in parallel. The mixtures were brought to a volume
of 500 l with modified RIPA buffer and further handled for the pull-down assay
as described above, including five subsequent wash steps before the elution.
Bacterial two-hybrid system to investigate protein-protein interactions. The
bacterial two-hybrid system BACTH, which was originally developed by Ladant,
Ullmann, and Karimova (25) and is now commercially available from EuroMEdEx Inc., was used to assess the potential interactions between H. pylori FlgM
and FlhAC in a bacterial native system (in E. coli). The BACTH plasmids pUT18
and pKNT25 were engineered to express FlgM and FlhAC (see Fig. S3 in the
supplemental material; primer sequences are also provided in the supplemental
material) as C-terminal fusion proteins to the T18 and T25 domains of Bordetella
pertussis adenylate cyclase (cya). Again, only the C-terminal soluble part of FlhA
was cloned into pKNT25 (FlhAC; cloning primers HP_FlhApKNT_fw and
HP_FlhApKNT_rvEco; resulting plasmid pCJ1001). FlgM was inserted into
pUT18, starting from the first possible start codon of the open reading frame
(primers HPFM24_fw and HPFM25_rvEco; resulting plasmid, pCJ1004).
pKT25-zip and pUT18C-zip plasmids (25) were used as a positive control for
protein-protein interactions. All possible single and double transformants of the
BACTH plasmids with and without inserts were prepared in E. coli BTH101
(Table 2). The plasmid content of the transformants was screened using Qiagen
plasmid spin columns, and protein expression of the transformants was detected
using polyclonal antisera against FlgM and FlhA in Western immunoblot assays.
Metabolic screening of the clones after transformation was performed on LuriaBertani plates supplemented with IPTG (0.2 mM) and 5-bromo-4-chloro-3indolyl-␤-D-galacatopyranoside (X-Gal; 40 g/ml) at 37°C as described in the
BACTH manual (EuroMedEx). Quantitative measurements of ␤-galactosidase
activities in the transformants were performed according to the method developed by Miller as described previously (24).

RESULTS
H. pylori FlgM is a predominantly cytoplasmic protein and
is only secreted in minor amounts into H. pylori flagella. In H.
pylori, a flagellar sheath envelopes the whole filament and is
continuous with the bacterial outer membrane. Under these
circumstances, it is not easy to envisage how FlgM could work
as a secreted regulator. Our hypothesis was that H. pylori FlgM
might undergo gain and loss of its regulatory anti-sigma function without the absolute requirement of secretion or might
not be secreted at all.
The potential for secretion of FlgM was first assayed by filter
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amplified before from H. pylori 26695 with primers (HPFM5 and FlgM_rev_2).
By sequencing pCJ606, the in-frame fusion of the flgM gene with the V5 tag was
checked. For cloning into pHel2, which was required for expression in trans in H.
pylori, the FlgM-V5 gene fusion was amplified from the plasmid pCJ606 using
primers (HPFM5 and OLV5_R, BamHI sites), which introduced a stop codon at
the 3⬘ end. The amplified gene was cloned into the BamHI site of pHel2
(resulting shuttle plasmid, pCJ607; FlgM-V5). pCJ607 was then introduced into
the N6flgM mutant using natural transformation. Plasmid-containing transformant clones were selected on kanamycin-chloramphenicol-containing medium
and characterized. The expression of the FlgM-V5 fusion protein was assessed by
Western blotting. Primer sequences used for amplification and cloning are available in the supplemental material.
Motility testing (motility plates). Motility testing was performed in semisolid
plates consisting of brucella broth supplemented with 0.3% agar and 3% fetal
calf serum (FCS), both as stab tests and as single colony motility tests as described previously (23).
Recombinant expression and purification of H. pylori FlhA and FlgM proteins
in E. coli. A partial C-terminal protein domain of approximately 46.5 kDa of H.
pylori FlhA (amino acids 351 to 732) was expressed as described previously using
plasmid pSUS225 (39). For technical reasons it was not feasible to overexpress
the complete H. pylori FlhA including its N-terminal membrane domain (39). H.
pylori FlgM was expressed in the pTWIN system (New England Biolabs, Cambridge, MA) as a C-terminal FlgM-intein-chitin binding domain fusion protein.
FlgM was cloned into the pTWIN1 C-term vector (according to the New England
Biolabs information manual) by PCR and ligation. Plasmid pCJ309 obtained in
E. coli DH5␣ was characterized and verified by nucleotide sequencing of the
complete insert. The expression of the fusion construct in E. coli ER2566 (New
England Biolabs) was induced at early exponential phase by administering 0.5
mM isopropyl-␤-D-thiogalactopyranoside (IPTG) for 4 h at 37°C. Purification of
the fusion protein was performed by affinity chromatography using a chitin
column as recommended by the manufacturer (New England Biolabs information manual). Binding to the column was followed by an overnight purification
step involving an intein autocleavage reaction in the presence of the reducing
agent dithiothreitol. Dithiothreitol causes the autocatalytic cleavage of the intein
domain from the fusion protein and enables the subsequent elution of an untagged version of the overexpressed protein (H. pylori FlgM). The eluted FlgM
was further purified by gel elution and repeated dialysis against phosphatebuffered saline.
Generation of antisera. An anti-HPFlhA antiserum raised against the recombinantly expressed C-terminal domain (FlhAc) was generated in rabbits as previously described (39). An antiserum directed against the recombinantly overexpressed and gel-purified untagged FlgM (described above) was raised in rabbits
(Eurogentec, Seraing, Belgium) by repeated intradermal injection.
Electron microscopy. Copper electron microscropy (EM) grids coated with
Formvar and carbon were directly placed on plate-grown bacteria to let them
stick and to negatively stain them with 1% phosphotungstate (pH 7.0). EM grids
were viewed in a Zeiss EM10 microscope at an acceleration voltage of 80 kV.
Immunofluorescence labeling and microscopy for intracellular detection of
tagged FlgM. Coverslips were coated with 0.3% gelatin and were placed directly
on plate-grown bacteria to let them attach. Liquid grown bacteria were also used
but did not become attached to the coverslips as reproducibly as plate-grown
bacteria. The bacteria were fixed with 2% paraformaldehyde in 100 mM phosphate buffer for 3 h and for another hour after exchanging the fixative with fresh
fixative. Nonadhering bacteria were removed by washing the coverslips four
times with 0.1% glycine in phosphate-buffered saline (PBS). To permeabilize the
fixed bacteria, they were incubated for 30 min with 0.1% Triton X-100. After
washing three times with PBS, the coverslips were incubated for 30 min in
blocking buffer (1% bovine serum albumin [BSA], 1% FCS in PBS). Due to a
weak GFP signal in H. pylori cells transformed with the FlgM-GFP fusion construct, the bacteria had to be immunostained with polyclonal anti-GFP antibodies (R970-01; Invitrogen). The bacteria were incubated overnight with the antiGFP antibodies diluted in blocking buffer (1:2,000). After washing four times
with 0.1% BSA in PBS, the fixed bacteria were incubated with secondary antibody (goat anti-rabbit Alexa488; 1:5,000; Invitrogen) for 1 h. The bacteria were
washed four times with 0.1% BSA in PBS and also three times with PBS. The
coverslips were mounted with the cell side down on a microscope slide with
mounting medium (2.5% DABCO in Mowiol) and dried overnight protected
from light. The coverslips were sealed with nail polish. Fluorescence microscopy
was performed using an Olympus BX40 microscope with a mercury light source
and a narrow-band-pass filter combination optimized for GFP detection (excitation at 490 nm, emission at 515 nm), outfitted with a ColorviewIII digital
camera (Olympus). Immunofluorescent labeling for the V5-tagged FlgM was
performed according to the same experimental protocol using mouse monoclo-
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concentrating supernatants of H. pylori wild-type bacteria
grown in liquid medium to different optical densities. In concentrated bacterial supernatants of wild-type H. pylori harvested from liquid culture at different time points from lag
phase to late exponential phase, almost no FlgM was detected
(Fig. 1). At very late time points of growth (an optical density
of 600 nm [OD600] of approximately 2.5), minor amounts of
FlgM were detected in the cell supernatants (Fig. 1). We then
attempted to determine the subcellular localization of FlgM in
H. pylori wild type further by crude fractionation, separating
the sheared-off fraction (containing flagellar material including
flagellar sheaths), soluble (expected to contain predominantly
cytoplasmic and periplasmic materials), and insoluble (crude
membranes) bacterial components (see Materials and Methods). In these experiments, we detected the bulk amount of
FlgM in the soluble fraction at all time points during growth
(Fig. 1). Osmolytic treatment of whole bacteria according to
the methods described in reference 1 (before and after shearing of flagella) (data not presented), intended to release
periplasmic proteins, did release some FlgM from the bacterial
bodies, but only in the presence of flagella. This finding suggested that the soluble part of FlgM is predominantly cytoplas-

mic and to some extent flagellum bound. In concordance, minor amounts of FlgM were also detected in the isolated
sheared-off flagellar preparations of wild-type bacteria, with an
increase of FlgM in this fraction at the onset of stationary
growth (Fig. 1).
We therefore concluded that FlgM is predominantly a cellbound and soluble cytoplasmic protein in H. pylori wild-type
bacteria, while small amounts of FlgM can be released into and
retained within the flagellar fraction, which includes the flagellar sheath.
FlgM is variably expressed in various H. pylori flagellar
mutants. Previous results indicated that FlgM cooperates
closely with FlhA to ensure the timely regulation of flagellar
class II and III regulons in H. pylori (33). We therefore hypothesized that flagellar basal body proteins, in particular
FlhA, are involved in the function and cytosolic localization of
H. pylori FlgM. Thus, in order to determine the requirements
for FlgM expression in H. pylori with regard to the presence of
different flagellar proteins and regulons, we tested a panel of
flagellar basal body and regulatory mutants in two different H.
pylori strains, N6 and 88-3887 (flhA, flhB1, flhB2, flhF, fliA, fliF,
fliI, fliP, and rpoN, which were generated and characterized in
our laboratory) (21, 24, 33, 39).
Analysis of whole-cell lysates (Fig. 2) by SDS-PAGE and
Western blotting against FlgM demonstrated that FlgM expression was low in flhB1, flhF, fliP, and rpoN allelic disruption
mutants and almost undetectable in isogenic flhB2, fliA, and
fliF disruption mutants. These results indicated that either
transcript abundance, translation, or stability of H. pylori FlgM
depended crucially on the flagellar basal body proteins FlhB1,
FlhB2, FlhF, FliF, and FliP, as well as on the flagellar sigma
factors RpoN and FliA. The latter result also corresponds with
earlier work performed in Salmonella, which determined that
FliA acts as a stabilizing type III secretion chaperone on FlgM
(2). In contrast, the fliI mutants expressed FlgM. Likewise, in
flhA mutants, which lack FlhA as a possible interaction partner
for FlgM (33), FlgM expression in whole-cell lysates appeared
to be similar to the wild type (Fig. 2).
FlgM displays a different subcellular distribution in H. pylori flhA mutants compared to wild-type bacteria. Since the
flagellar basal body protein FlhA was assumed to be an important cooperative or interactive partner of FlgM in H. pylori,
the next step was to investigate whether the subcellular localization of FlgM in H. pylori flhA mutant bacteria is altered in
comparison to the wild type. Therefore, we cultured H. pylori
flhA mutants in liquid media to different cell densities and
crudely fractionated them, as with the wild-type bacteria
above. We then analyzed these four fractions using Western
blotting and compared the fractions to those of the wild-type
bacteria.
In several experiments, less overall FlgM was detected in
flhA mutants after separation of the soluble and insoluble
fractions than in the crude lysate before fractionation of the
same flhA mutants (data not shown). This suggested that FlhA
might be involved directly or indirectly in stabilizing FlgM. In
contrast to the wild-type strain, where FlgM was predominantly detected in the soluble fraction, we recovered the highest amount of FlgM within the insoluble fraction of the flhA
mutant (Fig. 3). Very little FlgM was detected at all time points
in the soluble fraction. Thus, apparently, the soluble and cyto-
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FIG. 1. Localization of native FlgM in cellular fractions of H. pylori
wild-type bacteria. Bacteria (wild-type HP 88-3887) grown in liquid
culture were harvested in different growth phases (OD600 of 0.5 to 2.5)
and fractionated. Western blots after SDS-PAGE (16% acrylamide)
were incubated with anti-HPFlgM antiserum (1:200), and secondary
antibodies were goat anti-rabbit, peroxidase coupled (1:10,000). Tenmicroliter aliquots of the respective fractions were loaded in each lane.
The molecular mass of FlgM is designated by the arrows. IF, insoluble
fraction; CF, soluble fraction; EF, culture supernatant (external fraction); SF, sheared fraction (flagella-containing fractions).
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FIG. 3. Localization of native FlgM in fractions of H. pylori flhA
mutant bacteria. Bacteria (HP88-3887 flhA) grown in liquid culture
were harvested in different growth phases (OD600 of 0.5 to 2.5) and
fractionated. Western blots after SDS-PAGE (16% acrylamide) were
incubated with anti-FlgM antiserum (1:200), and secondary antibodies
were goat anti-rabbit, peroxidase coupled (1:10,000). Ten-microliter
aliquots of the respective fractions were loaded in each lane. The
molecular mass of FlgM is designated by the arrows. IF, insoluble
fraction; CF, soluble fraction; EF, culture supernatant (external fraction); SF, sheared fraction (surface associated, containing flagella).

plasmic localization of FlgM was decreased in the absence of
FlhA. Some FlgM was also recovered in the secreted supernatant of flhA mutants in later phases of growth. No FlgM was
detected in the sheared-off fraction. This was consistent with
expectations, since the H. pylori flhA mutants have been reported to lack flagellar formation and also the formation of
flagellar sheath structures (39).
Expression of tagged FlgM fusions and predominantly polar
localization of FlgM-V5 in H. pylori. Subsequently, in order to
investigate the localization of FlgM in situ with alternative
methods, two different expression plasmids were constructed
which produce tagged fusion proteins of FlgM at its C-terminal
end (FlgM-GFP and FlgM-V5). These shuttle plasmids coding
for FlgM fusions were transformed into H. pylori (strain N6)
flgM mutants for the FlgM-GFP plasmid and also into wildtype N6, N6 flhA, and fliI mutants (Fig. 4). Owing to gene copy
effects, genes encoded by the pHel2 derivative plasmids are
approximately fivefold overexpressed in H. pylori (data not
shown).
The tagged versions of FlgM were expressed in H. pylori
N6flgM(FlgM-GFP) and in the other FlgM-GFP transformants
(data not shown) and in N6flgM(FlgM-V5) (Fig. 5A). Both
fusion proteins were functional as inhibitory anti-sigma factors,
since they were able to diminish the transcript abundance for
most FliA-dependent class III genes (flaA; HP0472) and one
intermediate class flagellar gene (fliD) tested in the transformed strains to at least the level of wild type for FlgM-V5
(Fig. 4B) and to even lower levels for FlgM-GFP (Fig. 4A).
This was in contrast to flgM mutants, which showed higher
transcript levels than the wild type for class III and some
intermediate genes, as previously reported (24). FlgM-GFP
expression enhanced class II gene transcripts in comparison to
wild type, which was not observed for FlgM-V5 (Fig. 4A).
Bacteria expressing FlgM-GFP showed increased repression
abilities for class III genes in comparison to FlgM-V5, suggest-
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FIG. 2. FlgM expression in various H. pylori flagellar basal body mutants. FlgM expression in H. pylori wild-type strains (HPN6 and HP88) and
defined isogenic mutants in flagellar regulatory and basal body genes (whole-cell lysates; see Materials and Methods for descriptions of the
mutants) and flgM mutant (negative control). M, molecular mass marker. Approximately 10 g of total cell lysate protein for the upper panel or
30 g for the lower panel was loaded in each lane. Immunodetection was performed using anti-H. pylori FlgM antiserum (1:300).
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ing that the anti-sigma factor effect of the GFP fusion is stronger than that of wild-type FlgM and FlgM-V5 (Fig. 4) or that
repression by FlgM-GFP does not become appropriately relieved.

FIG. 5. Localization of FlgM-V5 in subcellular fractions of H. pylori
and in intact bacteria. (A) FlgM-V5 was detected in fractions of H.
pylori N6flgM(pCJ607) using anti-V5 monoclonal antibody (1:3,000;
Invitrogen; secondary antibody was goat anti-mouse peroxidase coupled, at 1:15,000). Bacteria were cultured on plates for 2 days. SF,
sheared-off surface-localized fraction; IF, insoluble fraction; CF, soluble fraction. (B) FlgM was localized by immunofluorescence on fixed,
permeabilized intact H. pylori N6flgM(pCJ607) bacteria expressing
FlgM-V5, using anti-V5 antibody (1:500; secondary antibody was goat
anti-mouse Alexa 488 at 1:5,000). (C) Fluorescence micrograph after
control labeling of intact, nontransformed H. pylori N6 wild type using
the same antibodies.

GFP is a 27-kDa protein tag and, to a large extent, gets
folded into its barrel-like three-dimensional structure in the
bacterial cytoplasm in the presence of oxygen (49). Therefore,
the secretion of proteins through the narrow channel of the
flagellar secretion system is largely abolished by GFP tagging
(19) (unpublished data). V5 is a short epitope tag (14 amino
acids) which can be used as a specific tag for fluorescence
immunodetection and is not predicted to hamper type III secretion. The morphology of the transformants expressing
FlgM-GFP was characterized by the lack of flagella, whereas
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FIG. 4. Flagellum-related transcripts in H. pylori transformants expressing tagged FlgM. Shown is the detection of selected flagellar
transcripts in H. pylori (HP) N6(FlgM-GFP), HPN6flhA(FlgM-GFP),
HPN6flgM(FlgM-GFP), HPN6fliI(FlgM-GFP), and HPN6flgM(FlgM-V5)
transformants in comparison to HPN6 wild type. (A) FlgM-GFP-expressing strains; (B) FlgM-V5-expressing flgM(FlgM-V5). flhA and fliI
flagellar basal body protein mutants with defined defects in the flagellar assembly process (described in Materials and Methods) transformed with FlgM-GFP-expressing plasmid were used as controls for
transcript-level comparison with transformed flgM and wild-type bacteria. Relative transcript amounts of selected regulatory and flagellar
genes of different hierarchical classes were determined using semiquantitative PCR on equivalent amounts of cDNA (RNA preparation
performed from liquid cultures, all bacteria harvested at an equivalent
OD600 of approximately 1.6). fcr, flagellar regulatory class; fc1, flagellar
class 1; fc2, flagellar class 2; fc3, flagellar class 3; fci, flagellar intermediate
class (see reference 33). In flgM mutants which are not depicted here,
transcripts of class 3 genes HP0472 and flaA are highly upregulated (24).
The respective gene names are shown on the right side. ⫺, negative
control. H. pylori 16S rRNA-specific primers were used to control for
equivalent amounts of cDNA.
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FIG. 6. Recombinantly expressed H. pylori FlhAC pulls down purified H. pylori FlgM. Results of a Western immunoblot analysis after
pull down of overexpressed H. pylori His6-FlhAC contained in E. coli
lysate, which was mixed with purified H. pylori FlgM are shown. Western blots were immunolabeled using anti-HPFlhA (1:2,000) and antiHPFlgM (1:300) polyclonal antisera. Various samples of the coprecipitation procedure are depicted: lanes 1, 2, and 3 are from a control
experiment containing FlhAC lysate only (“without FlgM”); lanes 4, 5,
and 6 are from one representative pull-down experiment (out of three
similar experiments) combining both FlhAC-containing lysate and purified FlgM (“with FlgM”). Lanes 1 and 4, starting material of FlhACcontaining lysate, either combined (lane 4) or not (control; lane 1) with
purified FlgM; lanes 2 and 5, the eluted material from TALON resin
after pull down. Lanes 3 and 6, the last wash steps of the TALON resin
prior to elution.

cess, which requires alternative strategies. A subsequent approach simulated more-physiological conditions and included
the possibility that FlgM and FlhA might cooperate indirectly,
aided by other proteins. This approach included only one purified partner, nontagged FlgM, which was combined in solution with whole-cell lysate of His6-FlhAC-expressing E. coli.
This combination finally yielded a reproducible interaction between FlgM and FlhAC in pull-down assays (Fig. 6). Hence,
FlgM was suggested to be able to interact with FlhAC, either
directly or indirectly.
As a further strategy to support our interaction results, we
used a bacterial two-hybrid system (BACTH) in order to assess
the interaction potential of those two molecules in a native
physiological environment inside the bacterial cell. Clones expressing C-terminal fusion proteins between FlhAC (pCJ1001)
or FlgM (pCJ1004) and the T25 or T18 domains of Bordetella
pertussis adenylate cyclase and appropriate positive and negative controls (see Materials and Methods; see also Fig. S3 in
the supplemental material) were cotransformed into the
BACTH expression strain E. coli BTH101. Only bacteria cotransformed with both FlgM and FlhAC plasmids and the positive control consistently gave rise to blue colonies on IPTG–
X-Gal–containing plates (see Fig. S3 in the supplemental
material). We could detect expression of both fusion proteins
in Western blot assays by using anti-HPFlhA and anti-HPFlgM
antisera (data not shown). In ␤-galactosidase assays, negative
controls and single FlgM-T18 transformants (in combination
with empty pKNT25) did not produce activities above background. The doubly flhAC-t25- and flgM-t18-transformed bacteria consistently yielded values of at least 7% of the ␤-galactosidase activities obtained from a positive control (Table 3).
Taken together, these findings indicate that H. pylori FlgM and
the cytoplasmic domain of the flagellar basal body protein
FlhA (FlhAC) are able to interact with each other.
DISCUSSION
Although only a few eubacterial species possess flagellar
sheaths (e.g., Vibrio cholerae, Bdellovibrio bacteriovorus, Rose-
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the FlgM-V5-expressing bacteria possessed flagella (data not
shown). These results suggested that FlgM-V5 permits the
chronology of events that lead to flagellar assembly to take
place, whereas FlgM-GFP does not.
Fractionation of bacteria expressing FlgM-GFP and
FlgM-V5 was performed. Neither tagged FlgM version was
secreted into the culture supernatants (data not shown), as
shown for wild-type FlgM. Western blot analysis revealed that
FlgM-V5 was localized both in the soluble fraction and in the
insoluble fraction (Fig. 5A), while FlgM-GFP localized predominantly to the insoluble fraction (data not shown). Some
FlgM-V5 was also detected in the sheared off-fraction (Fig.
5A), similar to the nontagged native FlgM (Fig. 1). Furthermore, fluorescent immunolabeling was performed for both fusion constructs in order to localize the tagged FlgM versions in
intact bacteria. In fluorescence microscopy of live and fixed
bacteria, GFP fluorescence of the FlgM-GFP fusion was quite
low and did not allow protein localization in microscopy (22).
We therefore used very specific anti-GFP and anti-V5 antibodies for immunofluorescent labeling of both fusion proteins in
intact bacteria (see Materials and Methods). Control strains
not expressing the fusion proteins were negative in fluorescence microscopy, whereas a clear signal could be observed
with both FlgM fusions. As the regulatory and morphological
phenotype of the transformed FlgM-V5 bacteria resembled
wild-type bacteria, we continued the immunolocalization approach using only the FlgM-V5 fusion. For FlgM-GFP, severe
changes in morphology and regulatory phenotype indicated
clogging of the flagellar secretion channel and possibly other
side effects, for which reason we did not continue localization
studies with this strain. The FlgM-V5-specific signal in immunofluorescence microscopy was predominantly polar (Fig. 5B).
Despite repeated attempts, it was not possible to obtain transformants with the FlgM-V5 plasmid in a flhA mutant. Therefore, FlgM-V5 localization in situ in this mutant could not be
determined.
Interaction between H. pylori FlgM and FlhAC. In order to
gain some insight into the molecular basis of the function and
subcellular localization of H. pylori FlgM in cooperation with
FlhA as hypothesized earlier, we investigated the potential for
interaction between FlgM and FlhA. For this purpose, the
soluble C-terminal domain of H. pylori FlhA, which is supposed
reach into the bacterial cytoplasm (37, 47), was overexpressed
as a His6-tagged fusion protein in E. coli and then purified as
previously described (39). H. pylori FlgM was also expressed
and purified from E. coli (see Materials and Methods). Using
both H. pylori FlgM and FlhAC as highly purified proteins after
overexpression in E. coli, we observed a nonreproducible interaction of the two proteins in coprecipitation experiments
(data not shown). Surface plasmon resonance analysis, using
the same purified proteins in standard buffers, posed persistent
technical problems and yielded no clear interaction profile. In
a second biosensor setup using a Biolayer Interferometry platform, immobilized purified FlgM was screened against bacterial lysate containing H. pylori FlhA, but this method also failed
to detect binding (see the supplemental material). Neither did
we observe an interaction between purified denatured FlhAC
and FlgM in overlay blot assays (data not shown). Thus, we
hypothesized that the folding of one or both interaction partners might be hampered during or after the purification pro-
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TABLE 3. ␤-Galactosidase assays of transformants for BACTH system suggest interaction of FlgM and FlhACa
␤-Galactosidase activity (% of control) ina:
Expt 1

Sample (doubly transformed E. coli BH101)

Expt 3

%

MU

%

MU

%

ND
⫺20
7,622
7,178
508
324
ND

ND
0
100
94.2
6.7
4.3
ND

0
⫺1
4,147
3,881
293
172
ND

0
0
100
93.6
7.1
4.1
ND

0
ND
1,188
ND
547
329
48

0
ND
100
ND
46
27.6
4

a
Activities in Miller units (MU) and percentage of positive control for BACTH cotransformants in E. coli BTH101 from three separate induction experiments are
depicted. One or two separate cultures of each transformation (induced from mid-log growth with 0.2 mM IPTG, 37°C for 3 h) were tested for each experiment in the
␤-galactosidase activity assay. All presented values are mean values of duplicate measurements. ND, not determined.

buria cecicola), most Helicobacter species including H. pylori do
possess a flagellar sheath. This probably serves to protect the
flagellar apparatus and filament from inactivation in the harsh
environment within the intestinal mucus of various animals,
which is rich in proteolytic activity and mucosal antibodies and
has a low pH. Possession of a flagellar sheath is likely to
hamper FlgM secretion, which was one initial motivation to
study FlgM secretion and function in H. pylori.
The present investigations revealed that in H. pylori, FlgM is
a predominantly soluble cytoplasmic protein. It is released into
the flagellar compartment in only low amounts and is not
detectable in cell supernatants during exponential growth. This
result could be a consequence of the shortened FlgM N terminus, which may have a lower propensity of being secreted.
Detection of FlgM in cell supernatants in late exponential
phase may be due to bacterial lysis. It cannot be excluded at
present that FlgM in H. pylori is released in larger amounts into
the periplasm, although several observations suggest this is not
the case. First, FlgM was found in the sheared-off flagellar
fraction, presumably inside the flagellar channel or collected
within the sheath surrounding the filament. Mild osmolytic
treatment of bacteria posterior to flagellar shearing did not
release FlgM from the bacterial cells and did not reduce the
amount of FlgM found in the bacteria-bound soluble fraction.
This argues against FlgM accumulating in the periplasm. In
Salmonella basal body and flk mutants, but notably not in the
wild type, FlgM was present in the periplasm, where it was
highly unstable (1). The possibility that FlgM is released into
the periplasm in H. pylori wild type and then quickly degraded
merits further investigation. Still, the fact that some FlgM
could be reproducibly detected in flagellar fractions in wildtype bacteria indicates that FlgM can stay stable upon its release. In a control experiment where H. pylori supernatants
were coincubated with purified H. pylori FlgM, FlgM remained
stable at room temperature for more than 2 h (M. Rust and C.
Josenhans, unpublished data). In contrast to our results in H.
pylori, FlgM in Vibrio cholerae was reported to be secreted into
the medium, although the bacteria possess sheathed flagella
(8). For that study, it was not discussed how FlgM secretion
outside of the sheath might take place.
Summarizing from our present data, FlgM is a predominantly cell-bound protein in H. pylori and very likely also in
other species of the Campylobacterales, which possess a short
FlgM. Our data imply that the H. pylori FlgM may exert its

regulatory functions predominantly without being secreted.
This is in contrast to Salmonella flagella, where the function of
FlgM is tightly connected to its secretion into the environment
through the flagellar type III secretion system (20). Cytoplasmic localization of the anti-sigma factor FlgM in H. pylori can
be partially explained by its interaction with the sigma factor
FliA, when FliA is in its inhibited state, before late flagellar
gene transcription is initiated.
However, as soon as FliA is released and becomes functional, which has to occur at later stages of flagellar assembly,
a different mechanistic explanation is required for the predominantly cytoplasmic localization of FlgM in H. pylori. We hypothesized that the recycling or shuttling of FlgM between an
active, FliA-bound state and an inactive noninhibitory state in
H. pylori is mediated by a mechanism which differs from the
loss of activity by abundant secretion. Several possibilities can
be envisaged, including FlgM being degraded by proteolysis or
interactions with different proteins when FlgM is not bound to
FliA. Using assays to test for FlgM stability in lysed or native
bacteria when protein synthesis was inhibited, we did not find
any evidence for FlgM being rapidly degraded (Rust and Josenhans, unpublished). For this reason, we focused on the
possibility that FlgM interacts with cytoplasmic proteins other
than FliA for being functionally inactivated, and one putative
candidate was FlhAC. Previously, data on flagellar regulation
in H. pylori wild type and various flagellar mutants (33) suggested that FlgM may act as an intergenic suppressor of the
flagellar basal body protein gene flhA and exerts its function in
close cooperation with FlhA. In the present study, the intrabacterial localization of FlgM was altered in the absence of
FlhA, providing further evidence for a close cooperation between these proteins. Furthermore, we gathered evidence that
FlgM interacts directly or indirectly with FlhAC.
We therefore propose a model for H. pylori and closely
related species in which the anti-sigma factor FlgM is predominantly retained in the cytoplasm and can be shuttled between
an active FliA-bound state and an inactive state. We propose
that FlgM may be bound to a different protein complex, after
being transferred from FliA to the flagellar basal body. One
binding partner is suggested to be the flagellar basal protein
FlhA, specifically, FlhAC. Interestingly, axial export substrates
of different substrate classes, including the late flagellar export
substrate flagellin (FliC), interacted directly with denatured
Salmonella FlhAC in a blot overlay system (31). So far, these
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